Mycobacterium tuberculosis membrane energetics and transport processes

Mycobacterium tuberculosis (Mtb) membrane energetics and transport processes encompass the essential machinery used by the bacterium to generate energy and maintain cellular homeostasis. This target area includes the oxidative phosphorylation system, which utilizes an electron transport chain to create a proton motive force that drives ATP synthesis via the F1F0-ATP synthase [1][4]. Additionally, it covers vital membrane transporters, such as the MmpL3 protein, which is responsible for the translocation of trehalose monomycolates required for cell wall assembly [3]. These processes are critical for Mtb survival across various physiological states, including active replication and dormancy within the host [4]. Therapeutic intervention in these pathways, exemplified by the ATP synthase inhibitor bedaquiline, has proven highly effective in treating multi-drug resistant tuberculosis [2]. Other agents like telacebec target the respiratory chain by inhibiting the cytochrome bc1-aa3 complex, further demonstrating the vulnerability of mycobacterial bioenergetics [5]. Because these bacterial systems often possess unique structural features compared to human homologs, they offer opportunities for high therapeutic selectivity. However, drug development in this space must carefully manage safety risks such as cardiotoxicity and ensure high selectivity to avoid interfering with human mitochondrial function [5]. Citations: [1] Andries K, et al. (2005). Science. [2] Mahajan R. (2013). Int J App Basic Med Res. [3] Grzegorzewicz AE, et al. (2012). Nat Chem Biol. [4] Cook GM, et al. (2014). J Biol Chem. [5] Pethe K, et al. (2013). Nat Med.

Other names

Mycobacterial oxidative phosphorylationMycobacterium tuberculosis respiratory chainMycobacterial membrane transport systemMtb bioenergetics

Drugs targeting these processes typically act by inhibiting the mycobacterial ATP synthase (e.g., bedaquiline), blocking the cytochrome bc1-aa3 respiratory complex (e.g., telacebec), or interfering with essential membrane transporters like MmpL3 (e.g., SQ109) to disrupt cell wall assembly and energy homeostasis.